Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results.
Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results.
复制标题
DOI：
10.1097/wad.0000000000000591
复制
发表时间：
2023-10-01
影响因子：
2.1
通讯作者：
中科院分区：
文献类型：
--
作者：
Alzheimer disease (AD) biomarker testing is now common in research and approaching clinical translation. Disclosure protocols must be informed by diverse participants’ perspectives on if/how the information would be useful. This study utilized semistructured interviews assessing interest in receiving positron emission tomography (PET) amyloid and tau results, as well as perceived risks and benefits of hypothetical PET disclosure as a function of race and participant diagnosis. Participants [39% Black; 61% White; M age=74.28 (5.98)] included 57 adults diagnosed as either cognitively healthy (58%) or with mild cognitive impairment (42%) and their respective care partners [33% Black; 67% White; M age=66.93 (10.92)]. Most dyads endorsed strong interest in PET results (82.5% of both participants and partners) regardless of race or diagnosis. Black care partners were less interested in receiving the participant’s results than White care partners (χ 2 (4)=8.31, P=0.047). Reasons for disclosure were diverse and highly personalized, including access to treatments or clinical trials (23.2% participants; 29.8% partners), advance planning (14.3% participants; 17.5% partners), and improved health knowledge (12.5% participants; 15.8% partners). In contrast, over 80% of respondents denied any risks of disclosure. Results suggest that predisclosure education, decisional capacity assessment, and a flexible disclosure approach are needed.
DOI：
10.1002/dad2.12384
发表时间：
2022
期刊：
Alzheimer's & dementia (Amsterdam, Netherlands)
影响因子：
--
作者：
通讯作者：
--